Abstract
Polyhydroxyalkanoates (PHA) are prokaryotic macromolecules accumulated within the cytoplasm as granules. Due to their suitable mechanical properties, biocompatibility, degradation time, ability to be blended, surface modified, and form copolymers, it is widely used in medical devices and as scaffolds in bone tissue engineering. This review describes in brief the production and extraction sources, physico-chemical characteristic, mechanical properties, degradation rate and applications of various PHAs and its copolymers with special emphasis to its role as scaffolds in bone tissue engineering.
Keywords: Polyhydroxyalkanoates, Polyhydroxybutyrate, Scaffolds, Bone tissue engineering
1. Introduction
Polyhydroxyalkanoates (PHA) are biocompatible and biodegradable polyesters accumulated within the cytoplasm of prokaryotic cells as water insoluble granules. PHA extracted from these granules exhibits good tensile strength, thermoplasticity and elastomeric nature. These properties of PHA and its polymers are comparable to bone and thus qualify them to be used as scaffolds for bone engineering.
2. PHAs
Polyhydroxyalkanoates (PHAs) are prokaryotic storage macromolecules, accumulated intracellularly as energy storage materials by various microorganisms under unbalanced specific growth conditions i.e. when the growth medium contains excess carbon (C), or low concentrations of nitrogen (N), phosphorus, or magnesium. These granules are often known as “carbonosomes” and are around 0.2–0.4 μm in diameter and contribute to more than 90% of the cell mass. Dyes like Sudan Black B and oxazine dyes like Nile Blue A or Nile Red can be used to stain the accumulated PHA in the cells.1
PHAs are aptly referred as ‘green plastics’ due to their positive social and environmental impact in production and recycling. With recent advancements, they can even be developed from non-PHAs producing strains with no toxins.2
3. PHYSIO-CHEMICAL characteristics
PHAs can be classified on the basis of the number of carbon atoms in the monomer incorporated into the polymers by their chain length; as short-chain-length PHAs (SCL-PHAs; 1-5-carbon atom monomer), medium-chain-length (MCL-PHA) with C6–C14 and long-chain-length (LCL-PHA) with >C14 monomers. The physicochemical properties of the PHAs may vary depending on their composition. While the SCL-PHA has properties similar to conventional plastics polyethylene or polypropylene, MCL-PHA has properties close to elastomers and rubbers. The SCL-PHA has high (60–80%) crystallinity, is stiff and brittle, while the MCL-PHA has low crystallinity, low glass transition temperature, low tensile strength and high elongation at break.3
The composition of PHAs varies depending upon the organism and their carbon substrate. Its molecular mass ranges between 200 and 300 kDa depending on the metabolic capability of the bacteria.4
The chief characteristics of PHA include non-antigenicity, biocompatibility, good tensile strength, enantiomeric purity, thermoplasticity and elastomericity.5 However, PHAs differ from other currently available biodegradable plastics due to moisture resistance, and water insolubility.6
4. Mechanical properties
The mechanical properties depend upon the monomeric composition of PHA, its chain length and the distance between R-group and ester linkage. Poly-3-hydroxybutyrate (P3HB) is SCL-PHA with 3-hydroxybutanoic acids units, is versatile and can be extruded, molded, spun into fibers, made into films or blended. It is stiff with a tensile modulus (3.5 GPa), tensile strength (40 MPa) and an elongation at break (6%) and shows good oxygen impermeability.7
Another member, poly 4-hydroxybutyrate (P4HB) is strong thermoplastic, malleable material, with tensile strength equivalent to polyethylene, flexible with 100% elongation at break, tensile modulus (0.15 GPa), tensile strength (104 MPa). PHB also presents piezoelectric properties, similar to natural bone.5 Though both are SCL-PHA and have equal number of carbon in their chains, they differ in R group positions, leading to difference in their 3D structure, polymer crystallinity and mechanical properties.8
Integration of 3-hydroxyvalerate (HV) units in PHB results in fabrication of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) or copolymer PHBV, with a lower melting point and crystallinity, tougher, better flexibility, and tolerance to thermal processing.9 PHBV is water insoluble and moisture resistant, does not degrade under normal conditions of storage, and is indefinitely stable in air.
Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) has lower crystallinity, broader processing window and higher elasticity compared with PHB and PHBV due to its long alkyl chain. It also possesses piezoelectric behavior and cytocompatibility when cultured with stem cells.10,11
Currently PHB, PHBV, P4HB, PHBHHx, copolymers of 3HB and 4-hydroxybutyrate (P3HB4HB), and poly-3-hydroxyoctanoate (PHO) are being used for tissue engineering.12
5. PHA production and extraction
PHA polymer, PHB/P3HB (Poly-3-hydroxybutyrate) was the first isolated and characterized in 1925 by Maurice Lemoigne. The main constraint lies in its high cost of production. However, currently several ways are being used to make the process cheaper, for example, using suitable bacterial strains and inexpensive carbon sources like those described in Table 1. Another cause of increased cost of production is the intracellular location of PHA along with complexity of the procedure of extraction. The methods employed for PHA production and extraction are described in brief in Table 2.
Table 1.
S no. | Chief content | Source |
---|---|---|
1 | Carbohydrates | Sugar beet molasses Starch and starch hydrosylates Maltose and Lactose from whey Cellulose hydrosylates Reject fiber wastes from the paper industry after hydrolysis |
2 | Alcohols | Wastes from biodiesel production Methanol and Glycerol |
3 | Fats and oils | Plant and animal wastes |
4 | Organic acids | Lactic acid from dairy industry |
Table 2.
S No. | Method of extraction | Description | Advantage/Disadvantage | Reference |
---|---|---|---|---|
1 | Solvent extraction | Chloroform is used as a solvent | High purity, without degradation of the PHA molecules, but the potential toxicity of the solvents is the problem | Yellore V & Desai A (1998) |
2 | Sodium hypochlorite Dissolution | Cellular mass is submerged in a sodium hypochlorite solution causing cell lysis followed by centrifugation to obtain PHA granules | Causes degradation of PHA | Ward A C & Dawes E A (1973), Heinrich D et al. (2012), Hahn et al. (1993) |
3 | Enzymatic degradation | Use of enzymes like proteases, trypsin bromelain, cellulose and lysozymes | High PHA yield without degradation, but these methods require heat treatment to break the cells. | Kanmani P et al. (2016) Choi and Lee (1999) |
4 | Centrifugal fractionation | The crop is pretreated with hexane for eliminating molecular lipids and oils, and then treated by 40%water/60% ethanol to eliminate soluble compounds like sugar | Up to 85% of PHA with purity higher than 95% can be obtained from continuous centrifugal fractionation | Chee JY et al., 2010 |
5 | Electrospinning | To produce nanometeric to micrometric polymeric fibers | Helpful for tissue engineering scaffold fabrication | Sill TJ et al., 2008 Smith IO et al., 2009 |
Porous scaffolds can be produced by thermally induced phase separation, evaporation, freeze-drying, solid-free fabrication, 3D printing, selective laser sintering, solvent casting, foam-coating, and many other techniques13
6. Degradation of PHA
PHAs are biodegradable although the rate of degradation observed is very slow and is primarily microbial ie. PHAs gets converted into CO2 and energy by microorganisms such as bacteria, fungi, and algae. Following degradation, the products pass though the cell wall and are metabolized. Tokiwa Y et al. (2004) demonstrated that PHB and PHBHV degrades in vivo to D-3- hydroxybutyrate (3HB), a common human blood constituent. Hence PHAs have an edge over other biodegradable polymers as are hydrolyzable, being degraded to soluble monomers without the help of other organisms.5 The hydrolysis products, 3HB and 4HB monomers, are natural metabolites that exist in brain, lung, heart, liver, kidney, muscle and expired as carbon dioxide from our body.14 Biodegradability of polymers is inversely related to melting point, crystallinity and molecular weight of the polymer15
7. Applications
Mechanical properties, biocompatibility, and degradation times of PHA make it suitable for application in tissue engineering. The fact that PHAs can be blended, surface modified, and form copolymers, enhances its application in medical devices and bone tissue engineering.
PHA, PHB, PHBV, P4HB, its composites and copolymers of 3-hydroxybutyrate, PHBHHx, and PHO are used to develop sutures, patches, slings, pins, barriers, stents, medical devices for guided tissue regeneration, cartilage or tendon repair, nerve guides, bone scaffolds, and wound dressings16
8. PHA as biomaterial for bone scaffolds
PHA and its composites possess several characteristics to qualify as biomaterial for scaffolds. When compared to other polymers like polylactide-co-glycolid (PLGA), polyglycolic acid (PGA), and polylactic acid (PLA), PHB scaffolds local pH during degradation remains unchanged, making them well tolerated by immune system.17
Blend of P(HB-co-8%HV)/hydroxyapatite (30% w/w) has a mechanical compressive strength as of human bones (62 MPa), evokes lower inflammatory response and causes higher mineralization.18 Shishatskaya et al. (2004) and Volova et al. (2003) implanted rats with PHA sutures and observed them in long-term studies to find PHA threads remain active throughout and do not show any adverse effects.19
Ellis et al. prepared laser-perforated biodegradable scaffold films of PHBHV and observed that the human keratinocytes attached and grew on film surface, penetrated pores and reached the damaged tissue. The decreased crystallinity at pore edges enabled faster cell adhesion, growth and migration20
Puppi et al. blended PHBHHx with PCL by computer-aided wet-spinning to avoid any adverse effect on the PHA molecular mass and provide pre-defined macro- and micro-porosity in the scaffold. They observed successful adhesion and proliferation of pre-osteoblast cells.21 There are several successful reports on PHB and PHBV in vitro and in vivo, for bone tissue regeneration approaches.22 PHBHHx has been used in the form of micro-grooved membrane,23 aligned nanofibers23 or carbon nanotubes-loaded composite materials24 and has shown to support human mesenchymal stem cells in osteogenesis.
Various Additive manufacturing techniques like stereolithography and fused deposition modelling were used to develop a predefined scaffold shape and porosity at macro-to micrometric scale25 Despite the promising results, the narrow melt processing temperature window of this technique hindered its application in production of 3D PHA porous scaffolds. Now a days, a hybrid technique, computer-aided wet-spinning (CAWS), is gaining attention. This technique involves processing of PHBHHx into 3D scaffolds wherein, a computer-controlled deposition of a solidifying polymeric fiber extruded directly into a coagulation bath occurs.26
9. PHA blends
PHB has been explored extensively as a scaffold biomaterial and approved by FDA. However, PHB is highly crystalline with a brittle nature, a relatively long degradation time and hydrophobic in nature thus limiting its application.27,28 A number of studies have attempted to modify the material properties of PHB through blending.29,30 A 50: 50 (w/w) blend of PHB with PHBV has shown better support for attachment and proliferation of human osteoblast cells.31 Daranarong D et al. (2014) fabricated electrospun nanofibrous scaffolds using fibrous membranes of PHB with polyL-lactide-co--caprolactone (PLCL) and observed them to be more hydrophilic (<120°) with lower tensile strength, increased extension at break, greater adhesion. This scaffold showed enhanced proliferation and mitochondrial activity of cells. PLCL/PHB nanofibrous membranes have also shown to promote cell cycle progression and reduce the necrosis.32
Electrospun PHB/cellulose acetate (CA) blended nanofiber scaffolds altered the crystallization of PHB by formation of hydrogen bonds and the CA content increased the glass transition temperature. Percentage increase in PHB increased the tensile strength, yield strength and elongation at break of the blended nanofiber scaffolds and decreased the water contact angle. In vitro degradation rate of blended nanofiber scaffolds was much higher, and the cells showed better biocompatibility and were capable of cell adhesion and proliferation.33
When blends of PHBHHx and polyD,L-lactic acid (PDLLA) were fabricated into fibrous membranes by electrospinning, the mechanical properties of the electrospun fibrous membranes depended on the orientation of fibers. They had higher elongation; tensile strength and modulus. As PDLLA increased, the electrospun fibrous membranes showed higher elongation and lower tensile modulus. PDLLA degraded faster than PHBHHx.34
When PHA was used to prepare open porous microspheres of 300–360 μm diameter, it could be used as injectable carrier harbouring proliferating stem cells. In contrast to PLA, PHA presented a high in vitro cell adhesion of 93.4% with surface pores of 10–60 μm and interconnected passages of 8.8 μm average size, continuous proliferation for 10 days, improved differentiation, a stronger osteoblast-regeneration and protection of cells against stresses during injection, which allowed proliferation and migration of more living cells to the damaged tissues.35
When hydrophobic PHBHHx scaffolds were coated with a PHA granule binding protein fused with RGD peptide (PHAp-RGD), it enabled homogeneous spread of cells for better adhesion, proliferation and chondrogenic differentiation, more production of ECM and significantly more cartilage-specific sulphated glycosaminoglycans (sGAG) and total collagen content.36
10. Conclusion
The application of PHA as scaffold in bone tissue regeneration is quite recent, and has a lot of potential due to its biocompatibility. However, their major disadvantage is that mostly they are produced by microorganisms in stressful environments (lacking nitrogen, oxygen, magnesium phosphate or sulphate), that limits their availability and hence increases the cost of fabrication. One of these PHB has a high molar mass, a decreased biodegradation rate and low electronic density because of which it cannot absorb enough photons to produce high-contrast images and thus cannot be seen radiographically.
Declaration of competing interest
Authors have no conflict of interest to disclose.
Acknowledgements
ICMR Bioengineering: Biomaterial for designing of mandibular bony scaffold: Evaluation of polymer-ceramic nano composite scaffold with BMP for critical size mandibular defect.(5/3/8/290/2015-ITR: 28,09,800)
References
- 1.Lee S.Y. Bacterial polyhydroxyalkanoates. Biotechnol Bioeng. 1996;49(1):114. doi: 10.1002/(SICI)1097-0290(19960105)49:1<1::AID-BIT1>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
- 2.Raza Z.A., Abida S., Banat I.M. Polyhydroxyalkanoates: characteristics, production, recent developments and applications. Int Biodeterior Biodegrad. 2018;126:45–56. [Google Scholar]
- 3.Chen G.Q., Xu J., Wu Q., Zhang Z., Ho K.P. Synthesis of copolyesters consisting of medium‐chain‐length β‐hydroxyalkanoates by Pseudomonas stutzeri 1317. React Funct Polym. 2001;48:107–112. [Google Scholar]
- 4.Urtuvia V., Villegas P., Fuentes S., González M., Seeger M. Burkholderia xenovorans LB400 possesses a functional polyhydroxyalkanoate anabolic pathway encoded by the pha genes and synthesizes poly(3-hydroxybutyrate) under nitrogen-limiting conditions. Int Microbiol. 2018;21(1–2):47–57. doi: 10.1007/s10123-018-0004-3. [DOI] [PubMed] [Google Scholar]
- 5.Holmes P.A. Application of PHB: a microbially produced biodegradable thermoplastic. Phys Technol. 1985;16(1):32–36. [Google Scholar]
- 6.Ojumu T.V., Yu J., Solomon B.O. Production of polyhy-droxyalkanoates, a bacterial biodegradable polymer. Afr J Biotechnol. 2003;3(1):18–24. [Google Scholar]
- 7.Choi J., Lee S.Y. Process analysis and economic evaluation for poly(3-hydroxybutyrate) production by fermentation. Bioprocess Eng. 1997;17(6):335–342. [Google Scholar]
- 8.Larrañaga A., Fernández J., Vega A. Crystallization and its effect on the mechanical properties of a medium chain length polyhydroxyalkanoate. J Mech Behav Biomed Mater. 2014;39:87–94. doi: 10.1016/j.jmbbm.2014.07.020. [DOI] [PubMed] [Google Scholar]
- 9.López N.I., Pettinari M.J., Nikel P.I., Méndez B.S. Polyhydroxyalkanoates: much more than biodegradable plastics. Adv Appl Microbiol. 2015;93:73–106. doi: 10.1016/bs.aambs.2015.06.001. [DOI] [PubMed] [Google Scholar]
- 10.Wang Y.W., Wu Q., Chen G.Q. Attachment, proliferation and differentiation of osteoblasts on random biopolyester poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds. Biomaterials. 2004;25:669–675. doi: 10.1016/s0142-9612(03)00561-1. [DOI] [PubMed] [Google Scholar]
- 11.Gao Y., Kong L., Zhang L. Improvement of mechanical properties of poly(dl-lactide) films by blending of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) Eur Polym J. 2006;42:764–775. [Google Scholar]
- 12.Wu Q., Wang Y., Chen G.Q. Medical application of microbial biopolyesters polyhydroxyalkanoates. Artif Cells Blood Substit Immobil Biotechnol. 2009;37(1):1–12. doi: 10.1080/10731190802664429. [DOI] [PubMed] [Google Scholar]
- 13.Maquet V., Jerome R. Design of macroporous biodegradable polymer scaffolds for cell transplantation. Mater Sci Forum. 1997;250:15–42. [Google Scholar]
- 14.Nelson T., Kaufman E., Kline J., Sokoloff L. The extraneural distribution of -hydroxybutyrate. J Neurochem. 1981;37 doi: 10.1111/j.1471-4159.1981.tb04689.x. 1345–8. [DOI] [PubMed] [Google Scholar]
- 15.Nishida H., Tokiwa Y. Distribution of poly(β-hydroxybu-tyrate) and poly(ε-caprolactone) degrading microorganisms and microbial degradation behaviour on plastic surfaces. Polym Mater Sci Eng. 1992;67:137–138. [Google Scholar]
- 16.Chen G., Wu Q.Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials. 2005;26(33):6565–6578. doi: 10.1016/j.biomaterials.2005.04.036. [DOI] [PubMed] [Google Scholar]
- 17.Koller M. Biodegradable and biocompatible polyhydroxy-alkanoates (PHA): auspicious microbial macromolecules for pharmaceutical and therapeutic applications. Molecules. 2018;23(2):362–382. doi: 10.3390/molecules23020362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Galego N., Rozsa C., Sanchez R., Fung J., Vazquez A., Tomas J.S. Characterization and application of poly(b-hydroxyalkanoates) family as composite biomaterials. Polym Test. 2000;19(5):485–492. [Google Scholar]
- 19.Shishatskaya E.I., Volova T., Puzyr A.P., Mogilnaya O.A., Efremov S.N. Tissue response to the implantation of biodegradable polyhydroxyalkanoate sutures. J Mater Sci Mater Med. 2004;15:719–728. doi: 10.1023/b:jmsm.0000030215.49991.0d. [DOI] [PubMed] [Google Scholar]
- 20.Ellis G., Cano P., Jadraque M. Laser microperforated biodegradable microbial polyhydroxyalkanoate substrates for tissue repair strategies: an infrared microspectroscopy study. Anal Bioanal Chem. 2011;399:2379–2388. doi: 10.1007/s00216-011-4653-8. [DOI] [PubMed] [Google Scholar]
- 21.Puppi D., Morelli A., Chiellini F. Additive manufacturing of poly(3-hydroxybutyrate-co-3- hydroxyhexanoate)/poly(ε-caprolactone) blend scaffolds for tissue engineering. Bioengineering. 2017;4:49. doi: 10.3390/bioengineering4020049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Doyle C., Tanner E.T., Bonfield W. In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite. Biomaterials. 1991;12:841–847. doi: 10.1016/0142-9612(91)90072-i. [DOI] [PubMed] [Google Scholar]
- 23.Wang Y., Jiang X.L., Yang S.C. MicroRNAs in the regulation of interfacial behaviors of MSCs cultured on microgrooved surface pattern. Biomaterials. 2011;32:9207–9217. doi: 10.1016/j.biomaterials.2011.08.058. [DOI] [PubMed] [Google Scholar]
- 24.Wu L.P., You M., Wang D., Peng G., Wang Z., Chen G.Q. Fabrication of carbon nanotube (CNT)/poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) nanocomposite films for human mesenchymal stem cell (hMSC) differentiation. Polym Chem. 2013;4:4490–4498. [Google Scholar]
- 25.Mota C., Puppi D., Chiellini F., Chiellini E. Additive manufacturing techniques for the production of tissue engineering constructs. J Tissue Eng Regenerat Med. 2015;9:174–190. doi: 10.1002/term.1635. [DOI] [PubMed] [Google Scholar]
- 26.Leroy E., Petit I., Audic J.L., Colomines G., Deterre R. Rheological characterization of a thermally unstable bioplastic in injection molding conditions. Polym Degrad Stab. 2012;97:1915–1921. [Google Scholar]
- 27.Philip S., Keshavarz T., Roy I. Polyhydroxyalkanoates: biodegradable polymers with a range of applications. J Chem Technol Biotechnol. 2007;82(3):233–247. [Google Scholar]
- 28.Arcana M., Sulaeman A., Pandiangan K.D., Handoko A., Ledyastuti M. Synthesis of polyblends from polypropylene and poly(R,S)-β-hydroxybutyrate, and their characterization. Polym Int. 2006;55(4):435–440. [Google Scholar]
- 29.Cheng G., Cai Z., Wang L. Biocompatibility and biodegradation of poly(hydroxybutyrate)/poly(ethylene glycol) blend films. J Mater Sci Mater Med. 2003;14(12):1073–1078. doi: 10.1023/b:jmsm.0000004004.37103.f4. [DOI] [PubMed] [Google Scholar]
- 30.Chan R.T.H., Marçal H., Russell R.A., Holden P.J.H., Foster L.J.R. Application of polyethylene glycol to promote cellular biocompatibility of polyhydroxybutyrate films. Int J Polym Sci. 2011:9. Article ID 473045. [Google Scholar]
- 31.Sombatmankhong K., Sanchavanakit N., Pavasant P., Supaphol P. Bone scaffolds from electrospun fiber mats of poly(3-hydroxybutyrate), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) and their blend. Polymer. 2007;48(5):1419–1427. [Google Scholar]
- 32.Daranarong D., Chan R., Wanandy N., Molloy R., Punyodom W., Foster J. Electrospun polyhydroxybutyrate and poly(L-lactide-co-ε-caprolactone) composites as nanofibrous scaffolds. BioMed Res Int. 2014;2014:12. doi: 10.1155/2014/741408. Article ID 741408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zhijiang C., Yi X., Haizheng Y., Jia J., Liu Y. Poly(hydroxybutyrate)/cellulose acetate blend nanofiber scaffolds: preparation, characterization and cytocompatibility. Mater Sci Eng C. 2016;58:757–767. doi: 10.1016/j.msec.2015.09.048. [DOI] [PubMed] [Google Scholar]
- 34.Cheng M.L., Chen P.Y., Lan C.H., Sun Y.M. Structure, mechanical properties and degradation behaviors of the electrospun fibrous blends of PHBHHx/PDLLA. Polymer. 2011;52(6):1391–1401. [Google Scholar]
- 35.Wei D.X., Dao J.W., Chen G.Q. A micro-ark for cells: highly open porous polyhydroxyalkanoate microspheres as injectable scaffolds for tissue regeneration. Adv Mater. 2018;30(31) doi: 10.1002/adma.201802273. [DOI] [PubMed] [Google Scholar]
- 36.You M., Peng G., Li J. Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide. Biomaterials. 2011;32(9):2305–2313. doi: 10.1016/j.biomaterials.2010.12.009. [DOI] [PubMed] [Google Scholar]